Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-023064
Filing Date
2021-03-25
Accepted
2021-03-25 17:30:17
Documents
1
Period of Report
2021-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12154
  Complete submission text file 0001209191-21-023064.txt   13525
Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Nielsen Jack (Reporting) CIK: 0001602402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40215 | Film No.: 21773673

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)